These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 21784177)
1. Quantitative determination of the composition of multi-shell calcium phosphate-oligonucleotide nanoparticles and their application for the activation of dendritic cells. Sokolova V; Knuschke T; Buer J; Westendorf AM; Epple M Acta Biomater; 2011 Nov; 7(11):4029-36. PubMed ID: 21784177 [TBL] [Abstract][Full Text] [Related]
2. The use of calcium phosphate nanoparticles encapsulating Toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation. Sokolova V; Knuschke T; Kovtun A; Buer J; Epple M; Westendorf AM Biomaterials; 2010 Jul; 31(21):5627-33. PubMed ID: 20417963 [TBL] [Abstract][Full Text] [Related]
3. Combined Toll-like receptor agonists synergistically increase production of inflammatory cytokines in human neonatal dendritic cells. Krumbiegel D; Zepp F; Meyer CU Hum Immunol; 2007 Oct; 68(10):813-22. PubMed ID: 17961769 [TBL] [Abstract][Full Text] [Related]
4. Cellular MRI as a suitable, sensitive non-invasive modality for correlating in vivo migratory efficiencies of different dendritic cell populations with subsequent immunological outcomes. de Chickera S; Willert C; Mallet C; Foley R; Foster P; Dekaban GA Int Immunol; 2012 Jan; 24(1):29-41. PubMed ID: 22190576 [TBL] [Abstract][Full Text] [Related]
5. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen. Lee YR; Lee YH; Im SA; Yang IH; Ahn GW; Kim K; Lee CK Arch Pharm Res; 2010 Nov; 33(11):1859-66. PubMed ID: 21116790 [TBL] [Abstract][Full Text] [Related]
6. TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses. Schlosser E; Mueller M; Fischer S; Basta S; Busch DH; Gander B; Groettrup M Vaccine; 2008 Mar; 26(13):1626-37. PubMed ID: 18295941 [TBL] [Abstract][Full Text] [Related]
7. Neuropeptide signaling activates dendritic cell-mediated type 1 immune responses through neurokinin-2 receptor. Kitamura H; Kobayashi M; Wakita D; Nishimura T J Immunol; 2012 May; 188(9):4200-8. PubMed ID: 22474018 [TBL] [Abstract][Full Text] [Related]
8. Polyinosinic-polycytidylic acid-mediated stimulation of human gammadelta T cells via CD11c dendritic cell-derived type I interferons. Kunzmann V; Kretzschmar E; Herrmann T; Wilhelm M Immunology; 2004 Jul; 112(3):369-77. PubMed ID: 15196204 [TBL] [Abstract][Full Text] [Related]
9. MHC expression and chemokine production in the murine vagina following intra-vaginal administration of ligands to toll-like receptors 3, 7 and 9. Nurkkala M; Nordström I; Telemo E; Eriksson K J Reprod Immunol; 2007 Apr; 73(2):148-157. PubMed ID: 17081619 [TBL] [Abstract][Full Text] [Related]
11. Schistosoma mansoni soluble egg antigens are internalized by human dendritic cells through multiple C-type lectins and suppress TLR-induced dendritic cell activation. van Liempt E; van Vliet SJ; Engering A; García Vallejo JJ; Bank CM; Sanchez-Hernandez M; van Kooyk Y; van Die I Mol Immunol; 2007 Apr; 44(10):2605-15. PubMed ID: 17241663 [TBL] [Abstract][Full Text] [Related]
12. PolyI:C-induced reduction in uptake of soluble antigen is independent of dendritic cell activation. Tirapu I; Giquel B; Alexopoulou L; Uematsu S; Flavell R; Akira S; Diebold SS Int Immunol; 2009 Jul; 21(7):871-9. PubMed ID: 19505890 [TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of cepharanthine on dendritic cell activation and function. Uto T; Nishi Y; Toyama M; Yoshinaga K; Baba M Int Immunopharmacol; 2011 Nov; 11(11):1932-8. PubMed ID: 21856446 [TBL] [Abstract][Full Text] [Related]
14. Intracellular delivery of major histocompatibility complex class I-binding epitopes: dendritic cells loaded and matured with cationic peptide/poly(I:C) complexes efficiently activate T cells. Haenssle HA; Riedl P; Buhl T; Schardt A; Rosenberger A; Schön MP; Schirmbeck R Exp Dermatol; 2010 Jan; 19(1):19-28. PubMed ID: 19758325 [TBL] [Abstract][Full Text] [Related]
15. Immunoprotective activity of a Salmonid Alphavirus Vaccine: comparison of the immune responses induced by inactivated whole virus antigen formulations based on CpG class B oligonucleotides and poly I:C alone or combined with an oil adjuvant. Thim HL; Iliev DB; Christie KE; Villoing S; McLoughlin MF; Strandskog G; Jørgensen JB Vaccine; 2012 Jul; 30(32):4828-34. PubMed ID: 22634299 [TBL] [Abstract][Full Text] [Related]
16. Delivery of the TLR ligand poly(I:C) to liver cells in vitro and in vivo by calcium phosphate nanoparticles leads to a pronounced immunostimulation. Sokolova V; Shi Z; Huang S; Du Y; Kopp M; Frede A; Knuschke T; Buer J; Yang D; Wu J; Westendorf AM; Epple M Acta Biomater; 2017 Dec; 64():401-410. PubMed ID: 28963016 [TBL] [Abstract][Full Text] [Related]
17. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer. Jasani B; Navabi H; Adams M Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817 [TBL] [Abstract][Full Text] [Related]
18. [Inhibition of the growth of hepatocarcinoma xenograft in Balb/c mice induced by dendritic cells immunized with AFP cDNA fragement]. Zeng B; Liao AJ; Lu FG; Fang WY; Wang J Zhonghua Zhong Liu Za Zhi; 2010 Feb; 32(2):98-102. PubMed ID: 20403238 [TBL] [Abstract][Full Text] [Related]
19. Differential activation of dendritic cells by Toll-like receptor agonists isolated from the Gram-positive vaccine vector Streptococcus gordonii. Mayer ML; Phillips CM; Townsend RA; Halperin SA; Lee SF Scand J Immunol; 2009 Apr; 69(4):351-6. PubMed ID: 19284500 [TBL] [Abstract][Full Text] [Related]
20. Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms. Demedts IK; Bracke KR; Maes T; Joos GF; Brusselle GG Am J Respir Cell Mol Biol; 2006 Sep; 35(3):387-93. PubMed ID: 16627825 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]